Invest in

Fighting Fat

6.1%
6.4%
0.0%

Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See More
6.1%
6.4%
0.0%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for as low as $9.95.
Join over 100,000 Motif customers customizing, building, and sharing motifs.
Portfolio Index 1 YR Return
Open a Motif account to view and trade this thematic portfolio
Weight Segment & Stocks Symbol 1 YR Return
44.7% Diabetes Care 13.6%
15.3% Merck & Company Inc. (new) MRK 22.5%
12.3% 8xxx 8xxxxxx 8xx 8xx 88.8%
10.9% 8xxxxx 8xx 88.8%
2.9% 8xxxxxx 8xxxxxxx 8xxxxxxxxxx 8xxx 88.8%
2.8% 8xxxxxxxxxx 8xx 8xx 8xx 88.8%
0.6% 8xxxxxxx 8xx 8xxx 88.8%
41.0% Weight Management 24.0%
15.3% MEDIFAST INC MED 47.8%
14.4% NutriSystem Inc NTRI 19.8%
8.3% 8xxxxx 8xxxxxxx 8xxxxxxxxxxxx 8xx 8x 88.8%
1.9% 8x 8xxx 8xxxxxxxxxx 8xxx 8xx 8xx 88.8%
0.8% 8xxxx 8xxxxx 8xxxxxxx 8xxx 8xxx 88.8%
0.3% 8xxxxxx 8xxxxx 8xx 8xx 88.8%
0.1% 8xx 8xxxxxxx 8xxx 8xxxx 8 8xx 88.8%
14.3% Weight Loss Drugs 21.7%
14.3% 8xxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
Quotes delayed 15 mins. Currently Sep 20, 2019 7:02:15 PM. Fields are marked with -- when data is unavailable.